/HXL

HXL

Rights Issue

Updated 12 July 08:33 am

$0.013

HEXIMA LIMITED.

1D0.00%
1M0.00%
1Y0.00%
Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Fetching full price history for the first time — this can take a moment

Track your position in HXL

Sign in to TradeLedgr to record trades in HXL (HEXIMA LIMITED.) with broker-true precision and ATO-compliant reporting.

Recent Announcements

Commitments Test Entity - Third Quarter Activity Report
Capital Reconstruction
16 Apr 2026 1:29 AM
14KB
Update - Consolidation/Split - HXL
Capital Reconstruction
16 Apr 2026 1:16 AM
121KB
Results of Meeting
Results of Meeting
12 Mar 2026 9:55 PM
14KB
Consolidation/Split - HXL
Capital Reconstruction

Fundamentals

P/E Ratio

-99999.99x

Div Yield

0.00%

EPS

$-0.0055

Avg Vol

52W High

$0.031

52W Low

$0.027

Company Profile

Research and development of plant-derived proteins and peptides for applications as human therapeutics.

Corporate Website

Financial History

2025A

$-0.5M profit

$0.0M rev

2024A

$-0.9M profit

$0.1M rev

2023A

$-1.9M profit

$1.5M rev

HXL | HEXIMA LIMITED. — ASX Stock Data | TradeLedgr